Targeting angiogenesis for the treatment of prostate cancer

Autor Antonarakis, Emmanuel S, Carducci, Michael A
Vydáno 2012

Future Directions in Castrate-Resistant Prostate Cancer Therapy

Autor Antonarakis, Emmanuel S., Carducci, Michael A.
Vydáno 2010

Combining low-dose cyclophosphamide with GM-CSF–secreting prostate cancer immunotherapy enhances antitumor immune effects

Autor Antonarakis, Emmanuel S, Carducci, Michael A
Vydáno 2010

Use of androgen deprivation therapy in prostate cancer: indications and prevalence

Autor Connolly, Roisin M, Carducci, Michael A, Antonarakis, Emmanuel S
Vydáno 2012

Novel targeted therapeutics for metastatic castration-resistant prostate cancer

Autor Antonarakis, Emmanuel S., Carducci, Michael A., Eisenberger, Mario A.
Vydáno 2009

Acetylation and Histone Deacetylase Inhibitors in Cancer

Autor Kortenhorst, Madeleine S. Q., Carducci, Michael A., Shabbeer, Shabana
Vydáno v Cell Oncol (2006)

A Review of Pomegranate in Prostate Cancer

Autor Paller, Channing J., Pantuck, Allan, Carducci, Michael A.
Vydáno v Prostate Cancer Prostatic Dis (2017)

Management of bone metastases in refractory prostate cancer – role of denosumab

Autor Paller, Channing J, Carducci, Michael A, Philips, George K
Vydáno 2012

Bone-targeting agents in prostate cancer

Autor Suzman, Daniel L., Boikos, Sosipatros A., Carducci, Michael A.
Vydáno 2014

Contemporary Experience With Ketoconazole in Patients With Metastatic Castration-Resistant Prostate Cancer: Clinical Factors Associated With PSA Response and Disease Progression

Autor Keizman, Daniel, Huang, Peng, Carducci, Michael A., Eisenberger, Mario A.
Vydáno 2011

Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study

Autor Kanarek, Norma F, Kanarek, Marty S, Olatoye, Dare, Carducci, Michael A
Vydáno 2012

Role of Immunotherapy for Renal Cell Cancer in 2011

Autor George, Saby, Pili, Roberto, Carducci, Michael A., Kim, Jenny J.
Vydáno 2011

WHAT CAN I DO? RECOMMENDATIONS FOR RESPONDING TO ISSUES IDENTIFIED BY PATIENT-REPORTED OUTCOMES ASSESSMENTS USED IN CLINICAL PRACTICE

Autor Hughes, Elizabeth F., Wu, Albert W., Carducci, Michael A., Snyder, Claire F.
Vydáno 2012

Fenugreek: a naturally occurring edible spice as an anticancer agent

Autor Shabbeer, Shabana, Sobolewski, Michelle, Kachhap, Sushant, Davidson, Nancy, Carducci, Michael A., Khan, Saeed
Vydáno 2009

Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer

Autor Franke, Ryan M., Carducci, Michael A., Rudek, Michelle A., Baker, Sharyn D., Sparreboom, Alex
Vydáno 2010

Progression of Prostate Carcinogenesis and Dietary Methyl Donors: Temporal Dependence

Autor Shabbeer, Shabana, Williams, Simon A., Simons, Brian W., Herman, James G., Carducci, Michael A.
Vydáno 2011

Recent Time Trends in the Epidemiology of Stage IV Prostate Cancer in the United States: Analysis of Data From the Surveillance, Epidemiology, and End Results Program*

Autor Cetin, Karynsa, Beebe-Dimmer, Jennifer L., Fryzek, Jon P., Markus, Richard, Carducci, Michael A.
Vydáno v Urology (2009)

Changes in PSA Kinetics Predict Metastasis-Free Survival in Men with PSA-Recurrent Prostate Cancer Treated with Non-Hormonal Agents: Combined Analysis of 4 Phase II Trials

Autor Antonarakis, Emmanuel S., Zahurak, Marianna L., Lin, Jianqing, Keizman, Daniel, Carducci, Michael A., Eisenberger, Mario A.
Vydáno 2012

Risk Factors for Metastatic Prostate Cancer: A Sentinel Event Case Series

Autor Paller, Channing J., Cole, Alexander P., Partin, Alan W., Carducci, Michael A., Kanarek, Norma F.
Vydáno v Prostate (2017)

Prostate Cancer Update: Advanced Disease

Autor Carducci, Michael A, Crawford, E. David, Higano, Celestia S, Mendoza-Valdes, Arturo, Petrylak, Daniel P, Schalken, Jack
Vydáno 2003